MPS Powered by Eureka

Clinical Cancer Drugs

ISSN: 2212-697X (Print)
eISSN: 2212-6988 (Online)

Scopus
CiteScore:

1.3

Aims and Scope:Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues covering all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and pharmacologists.

Clinical Cancer Drugs is an international, peer-reviewed journal on all aspects of cancer drugs published continuously (print & online) by Bentham Science Publishers.

Editor-in-Chief:


Giulio Francia Department of Biological Sciences
The University of Texas
El Paso, TX
USA